Tech Company Financing Transactions
BG Medicine Funding Round
On 7/17/2008, BG Medicine raised $40 million in Series D funding from Flagship Pioneering, Humana and Legg Mason.
Transaction Overview
Company Name
Announced On
7/17/2008
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series D
Investors
Proceeds Purpose
The funding will enable BG Medicine to complete development and commercialization of the company's first two diagnostic products and continue discovery and development of additional product candidates.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
124 Washington St. 101
Foxboro, MA 02035
USA
Foxboro, MA 02035
USA
Phone
Website
Email Address
Overview
BG Medicine is a life sciences company developing biomarker-based diagnostic tests for the cardiovascular sectors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Sohmer
Chief Financial Officer
Stephen Hall
Chief Scientific Officer
Aram Adourian
Browse more venture capital transactions:
Prev: 7/17/2008: Business Insider venture capital transaction
Next: 7/17/2008: Nuventix venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs